The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Authors
Keywords
-
Journal
Biomedicines
Volume 11, Issue 3, Pages 687
Publisher
MDPI AG
Online
2023-02-24
DOI
10.3390/biomedicines11030687
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
- (2022) Pedro M Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine
- (2022) Sara K Tedeschi et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- (2022) Carlo Scognamiglio Renner Araujo et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
- (2022) Rebecca Grainger et al. Nature Reviews Rheumatology
- Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey
- (2022) Lisa G Rider et al. RHEUMATOLOGY
- Immunogenicity and Safety of Standard and Third Dose SARS‐CoV ‐2 Vaccination in Patients on Immunosuppressive Therapy
- (2022) Silje W Syversen et al. Arthritis & Rheumatology
- Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
- (2022) Chiara Farroni et al. Frontiers in Immunology
- Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases
- (2022) Roya M. Dayam et al. JCI Insight
- Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
- (2022) Kuo-Tung Tang et al. Biomedicines
- An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry—protocol and preliminary data
- (2022) Carolina A. Isnardi et al. CLINICAL RHEUMATOLOGY
- Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis
- (2022) Rebecca B Blank et al. RHEUMATOLOGY
- The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
- (2022) Yan Xie et al. Frontiers in Immunology
- Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
- (2022) Chiara Farroni et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis
- (2022) Naveen R et al. RHEUMATOLOGY
- Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
- (2022) Paola Stefanelli et al. Eurosurveillance
- Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)
- (2022) Margaret Ma et al. JOURNAL OF AUTOIMMUNITY
- Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
- (2021) Zhuofan Li et al. Vaccines
- Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
- (2021) Ekaterina Zmievskaya et al. Biomedicines
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis
- (2021) Anuraag Jena et al. AUTOIMMUNITY REVIEWS
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis
- (2021) Lars Erik Bartels et al. RHEUMATOLOGY INTERNATIONAL
- Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS‐CoV‐2 Messenger RNA Vaccination
- (2021) Caoilfhionn M. Connolly et al. Arthritis & Rheumatology
- ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
- (2021) Andrea Picchianti-Diamanti et al. Frontiers in Immunology
- Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
- (2021) Cinzia Rotondo et al. Vaccines
- Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
- (2021) Raffaele D'Amelio et al. Biomedicines
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2021) Sebastian Eduardo Sattui et al. RMD Open
- Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
- (2021) Laura Boekel et al. Lancet Rheumatology
- Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
- (2021) Xue Li et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines
- (2021) Yong Fan et al. ANNALS OF THE RHEUMATIC DISEASES
- A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
- (2021) Athanasios G. Tzioufas et al. JOURNAL OF AUTOIMMUNITY
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
- (2021) George E. Fragoulis et al. RHEUMATOLOGY INTERNATIONAL
- COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases
- (2021) Larisa Pinte et al. Journal of Personalized Medicine
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
- (2020) Robert BM Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- DNA Damage Response and Oxidative Stress in Systemic Autoimmunity
- (2019) Vassilis L. Souliotis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STARTER study
- (2018) Georgios Filippou et al. ANNALS OF THE RHEUMATIC DISEASES
- Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine
- (2018) Young J. Lee et al. Frontiers in Microbiology
- Vaccines, adjuvants and autoimmunity
- (2015) Luísa Eça Guimarães et al. PHARMACOLOGICAL RESEARCH
- Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals
- (2014) F. Milanetti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Could Autoimmunity Be Induced by Vaccination?
- (2010) Simonetta Salemi et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Are Anti-Infectious Vaccinations Safe and Effective in Patients with Autoimmunity?
- (2010) Simonetta Salemi et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started